|
COMMERCE BUSINESS DAILY ISSUE OF JUNE 2,1997 PSA#1857DHHS/PHS/FDA/Office Of Facilities, Acquisition, And Central Services,
Division of Contracts and Program Management, HFA-512(COB), 5600
Fishers Lane, Rockville, MD 20857 A -- IN VITRO MODELS FOR PREDICTING CLINICALLY RELEVANT INTERACTION
FOR DRUG METABOLIZED BY CYP2C9 -- AN IN VITRO-IN VIVO CORRELATION. SOL
223-97-3005 POC Deborah Striegel, Contracting Officer, 301-443-4420
The Food and Drug Administration, Center for Drug Evaluation and
Research, Office of Pharmaceutical Science, plans to procure this
research from the University of Pittsburgh, Pittsburgh, PA. This
organization has the necessary prerequisite research capability to
perform this work over a one year performance period plus four one year
option periods. See Numbered Note 22. (0149) Loren Data Corp. http://www.ld.com (SYN# 0007 19970602\A-0007.SOL)
A - Research and Development Index Page
|
|